Corinna Lanzarotti

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

L. Zhang, Shun Lü, J. Feng et al. · Annals of Oncology · 2017 · 105 citations · Full text

Netupitant PET imaging and ADME studies in humans

Tulla Spinelli, Selma Calcagnile, Claudio Giuliano et al. · The Journal of Clinical Pharmacology · 2013 · 57 citations · Full text

Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of midazolam, erythromycin, and dexamethasone

Corinna Lanzarotti, Giorgia Rossi · Supportive Care in Cancer · 2013 · 40 citations

Pharmacological Study, Medicine, Pharmacotherapy +2

Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives

Selma Calcagnile, Corinna Lanzarotti, Giorgia Rossi et al. · Supportive Care in Cancer · 2013 · 31 citations

Molecular Pharmacology, Oral Contraceptives, Pharmacological Study +8

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

Jianhua Chang, Gongyan Chen, Dong Wang et al. · Cancer Medicine · 2020 · 18 citations · Full text